For example, FGF23 may act as an autocrine, paracrine and/or endocrine growth factor in prostate cancer progression, but the relative importance of each factor depends on tumor expression level, tumor site, and underlying disease state [85]. This evidence concerns the gene FGF23 and prostate carcinoma.